Summit Therapeutics Inc. (SMMT) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 197.01K | 193.05K | 190.31K | 185.61K | 971.41K | 41.21K |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | -100% | -100% | -100% | -100% | -79.72% | 368.5% | 36.64% | 37.2% | 592.5% | -69.97% |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 197.01K | 193.05K | 190.31K | 185.61K | 971.41K | 41.21K |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 100% | 100% | 100% | 100% | 100% | 100% |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | -100% | -100% | -100% | -100% | -79.72% | 368.5% | 36.64% | 37.2% | 592.5% | -69.97% |
| Operating Expenses | 195.21M | 224.88M | 234.21M | 414.14M | 51.75M | 52.41M | 43.66M | 47.16M | 33.59M | 28.4M | 16.8M | 12.44M | 435.41M | 16.79M | 15.37M | 10.62M | 17.06M | 19.45M | 15.43M | 17.2M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7800.03% | 5500.87% | 8963.2% | 10477.35% | 1588.62% | 41731.59% |
| Selling, General & Admin | 62.59M | 77.58M | 103.11M | 262.58M | 12.06M | 11.53M | 15.25M | 10.93M | 9.13M | 9.08M | 4.45M | 4.97M | 5.63M | 6.27M | 4.99M | 5.7M | 5.07M | 5.75M | 4.2M | 4.33M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2533.19% | 2950.23% | 2663.6% | 3099.62% | 432.54% | 10498.25% |
| Research & Development | 132.62M | 147.29M | 131.1M | 151.56M | 39.68M | 41.04M | 28.22M | 36.23M | 24.47M | 19.46M | 12.56M | 7.44M | 430.26M | 4.46M | 15.27M | 7.4M | 15.65M | 17.09M | 14.8M | 17.29M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7749.58% | 3833.21% | 8222.4% | 9206.02% | 1523.53% | 41970.18% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | -163.74K | 197.46K | 0 | 0 | -140.41K | -217.21K | 21.26K | -473.5K | 1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K |
| Operating Income | -195.21M | -224.88M | -234.21M | -414.14M | -51.75M | -52.41M | -43.66M | -47.16M | -33.59M | -28.4M | -16.8M | -12.44M | -435.41M | -16.79M | -15.17M | -10.43M | -16.87M | -19.26M | -14.46M | -17.16M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -7700.03% | -5400.87% | -8863.2% | -10377.34% | -1488.62% | -41631.59% |
| Operating Income Growth % | -277.24% | -329.08% | -436.4% | -778.13% | -54.05% | -84.51% | -159.96% | -279.21% | 92.28% | -69.16% | -10.72% | -19.28% | -2481.28% | 12.82% | -4.9% | 39.22% | -37.4% | -127.93% | -10.14% | -38.43% |
| EBITDA | -195.17M | -224.83M | -234.17M | -414.11M | -51.73M | -52.39M | -43.65M | -47.15M | -33.57M | -28.38M | -16.77M | -12.4M | -435.34M | -16.54M | -14.89M | -10.15M | -16.63M | -19.02M | -14.21M | -16.9M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -7559.12% | -5260.02% | -8736.4% | -10246.67% | -1462.87% | -41022.82% |
| EBITDA Growth % | -277.3% | -329.14% | -436.48% | -778.37% | -54.09% | -84.6% | -160.28% | -280.19% | 92.29% | -71.59% | -12.61% | -22.12% | -2518.31% | 13.03% | -4.8% | 39.93% | -38.17% | -134.35% | -10.83% | -39.67% |
| D&A (Non-Cash Add-back) | 44K | 42K | 42K | 27K | 19.35K | 17.57K | 14.96K | 15.82K | 21.4K | 23.53K | 26.23K | 36.22K | 72.95K | 252.3K | 277.6K | 271.92K | 241.32K | 242.55K | 250.09K | 250.86K |
| EBIT | -195.21M | -219.12M | -231.79M | -414.14M | -51.75M | -52.41M | -43.66M | -35.29M | -33.59M | -28.4M | -16.8M | -12.44M | -13.16M | -10.83M | -15.17M | -10.43M | -16.87M | -19.26M | -14.46M | -17.16M |
| Net Interest Income | 0 | 0 | 0 | 2.98M | 0 | 13.46M | -2.46M | -3.1M | -3.12M | -522K | -237K | 771K | -8.33M | -2.9M | -692K | -653K | -152K | -1.05M | -113K | -216K |
| Interest Income | 0 | 0 | 0 | 2.98M | 0 | 13.47M | 0 | 0 | 0 | 2.38M | 2.48M | 3.29M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 9K | 2.46M | 3.1M | 3.12M | 2.9M | 2.72M | 2.52M | 8.33M | 2.9M | 692K | 653K | 152K | 1.05M | 113K | 216K |
| Other Income/Expense | 5.79M | 5.75M | 2.42M | 1.99M | 3.05M | 3.52M | 1.59M | -607.54K | -859.04K | -280.04K | -636.06K | 848.06K | -4.23M | 885.13K | -3.98M | -3.35M | 579.32K | -777.92K | -83.86K | -495.93K |
| Pretax Income | -189.42M | -219.12M | -231.79M | -412.15M | -48.7M | -48.89M | -42.08M | -47.77M | -34.45M | -28.68M | -17.43M | -11.59M | -439.64M | -15.91M | -19.15M | -13.78M | -16.29M | -20.04M | -14.54M | -17.65M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -9720.49% | -7136.63% | -8558.8% | -10796.47% | -1497.25% | -42835.1% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -189.42M | -219.17M | -231.79M | -412.15M | -48.7M | -48.89M | -42.08M | -47.77M | -34.45M | -28.68M | -17.43M | -11.59M | -439.64M | -15.91M | -19.15M | -13.78M | -16.29M | -20.04M | -14.54M | -17.65M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -9720.49% | -7136.63% | -8558.8% | -10796.47% | -1497.25% | -42835.1% |
| Net Income Growth % | -288.97% | -348.34% | -450.9% | -762.81% | -41.36% | -70.43% | -141.36% | -312.2% | 92.16% | -80.33% | 8.97% | 15.89% | -2599.08% | 20.62% | -31.67% | 21.94% | -28.4% | -102.38% | -5.77% | -43.14% |
| Net Income (Continuing) | -189.42M | -219.12M | -231.79M | -412.15M | -48.7M | -48.89M | -42.08M | -47.77M | -34.45M | -28.68M | -17.43M | -11.59M | -439.64M | -15.91M | -19.15M | -13.78M | -16.29M | -20.04M | -14.54M | -17.65M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.24 | -0.29 | -0.31 | -0.56 | -0.07 | -0.07 | -0.06 | -0.07 | -0.05 | -0.04 | -0.03 | -0.02 | -1.16 | -0.06 | -0.13 | -0.14 | -0.17 | -0.21 | -0.15 | -0.20 |
| EPS Growth % | -244.33% | -305.03% | -418.39% | -686.52% | -41.96% | -75.06% | -139.2% | -328.92% | 95.77% | 31.14% | 80.77% | 88.14% | -582.35% | 71.71% | 13.33% | 30% | -13.33% | -61.54% | 25% | -5.26% |
| EPS (Basic) | -0.24 | -0.29 | -0.31 | -0.56 | -0.07 | -0.07 | -0.06 | -0.07 | -0.05 | -0.04 | -0.03 | -0.02 | -1.16 | -0.06 | -0.13 | -0.14 | -0.17 | -0.21 | -0.15 | -0.19 |
| Diluted Shares Outstanding | 775.46M | 766.4M | 743.42M | 742.62M | 738.08M | 737.5M | 726.66M | 707.9M | 701.78M | 700.6M | 697.74M | 697.68M | 378.16M | 274.7M | 148.58M | 99.65M | 98.07M | 96.78M | 98.97M | 92.07M |
| Basic Shares Outstanding | 775.46M | 766.4M | 743.42M | 742.61M | 699.04M | 683.17M | 703.17M | 670.94M | 701.79M | 700.61M | 697.75M | 697.69M | 378.16M | 267.93M | 148.58M | 99.65M | 98.07M | 96.72M | 97.99M | 90.43M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |